Evaluation of the SMART IBD App Digital Therapeutic Tool for Pediatric Inflammatory Bowel Disease
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.
• Confirmed diagnosis of IBD (Crohn's Disease, ulcerative colitis, or indeterminate colitis)
• Prescribed at least one daily or weekly medication for treatment of IBD
• \<86% adherence to prescribed medication
• Access to internet via Wi-Fi or data plan and access to smartphone
• English fluency for patient and caregiver